Search

The drug provides a new treatment option for people whose cancer has stopped responding to other therapies.

… Thursday, July 26, 2018 The US Food and Drug Administration has approved the drug ivosidenib (Tibsovo ® ) for the treatment of certain people with acute myeloid leukemia (AML) that has stopped responding to other therapies. Memorial Sloan Kettering hematologist-oncologist  Eytan Stein was a co-leader

The new findings suggest the need for caution when interpreting the results from these tests.

… Monday, November 25, 2019 Summary A comprehensive analysis led by researchers at Memorial Sloan Kettering has found that a large proportion of mutations found in liquid biopsies do not come from tumor cells, but rather from alterations in white blood cells. Blood tests called liquid biopsies have raised

Leukemia cells metabolize fructose in a way that could make them easier to target with drugs.

… Tuesday, December 22, 2020 Summary The way cancer cells process fructose has not been closely studied by researchers. A new study shows that some leukemia cells can break down fructose using a different metabolic pathway. This raises the possibility that giving fructose combined with drugs could be an

MSK patients will remain in-network to continue receiving world-class cancer care.

… Monday, December 23, 2024 MSK patients will remain in-network to continue receiving world-class cancer care Anthem Blue Cross and Blue Shield in New York and Memorial Sloan Kettering Cancer Center (MSK) announced today that the organizations have reached a new multi-year agreement providing Anthem members

Los pacientes de MSK seguirán dentro de la red y podrán seguir recibiendo atención oncológica de primer nivel.

… Monday, December 23, 2024 Los pacientes de MSK seguirán dentro de la red y podrán seguir recibiendo atención oncológica de primer nivel Anthem Blue Cross and Blue Shield en Nueva York y Memorial Sloan Kettering Cancer Center (MSK) anunciaron hoy que las organizaciones llegaron a un nuevo acuerdo plurianual

Центр MSK останется поставщиком, входящим в список рекомендованных, а наши пациенты по-прежнему будут получать онкологическую помощь мирового класса

… Monday, December 23, 2024 Центр MSK останется поставщиком, входящим в список рекомендованных, а наши пациенты по-прежнему будут получать онкологическую помощь мирового класса Ассоциация страховщиков Anthem Blue Cross and Blue Shield в Нью-Йорке и Memorial Sloan Kettering Cancer Center (MSK) объявили

MSK 患者仍将留在网络内，继续接受世界一流的癌症照护服务。

… Monday, December 23, 2024 MSK 患者仍将留在网络内，继续接受世界一流的癌症照护服务 位于纽约的 Anthem Blue Cross and Blue Shield 与 Memorial Sloan Kettering Cancer Center (MSK) 今天宣布，两家机构已达成一项新的多年期协议，为 Anthem 旗下会员提供在纽约及周边地区 MSK 医院、门诊护理中心和医生办公室继续就医的机会。 根据新合同，Anthem 雇主医疗计划的成员将可以在 MSK 医生和设施处不间断地接受网络内就诊。 MSK 还将继续为 Anthem 的 Medicaid 和基本健保计划

Dr. Thompson and MSK are being recognized with this prestigious award for leadership during the ongoing COVID-19 pandemic.

… Wednesday, October 21, 2020 Memorial Sloan Kettering (MSK) President and CEO,  Craig B. Thompson, MD , has been awarded Columbia Business School’s Deming Cup for Operational Excellence. Dr. Thompson and MSK are being recognized with this prestigious award for leadership during the ongoing COVID-19 pandemic

New research from MSK offers a window into patients’ complex decision-making around adjuvant therapy, explores the promise of engineered CAR T cells, highlights the success of a summer research program to support groups underrepresented in science, and more.

… Thursday, February 23, 2023 New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute — a hub for basic science and translational research at MSK — offers a window into patients’ complex decision-making around adjuvant therapy; explores the promise of engineered

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Wednesday, July 15, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: The Pershing Square Foundation Awards $3 Million to SARS-CoV-2 Research Projects Benjamin Greenbaum, PhD Matthew Hellmann, MD Jedd Wolchok, MD Christine Mayr, MD, PhD Santosha Vardhana